LGR6 and Hyperglycemia: Knocking down LGR6 in cells blocked the beneficial effects of MaR1 on reducing ROS and inflammation, further confirming that LGR6 is essential for the actions of MaR1, reduced hyperglycemia, and slowed the pathological progression of kidney damage.